About US
YARDY Ventures has invested years building the foundation of a “Hybrid” Venture Capital company. Our multi-national, multi-cultural and multi-discipline team
have a deep understanding of Artificial Intelligence, Biotechnology, Digital Health, Blockchain, Internet of Medical Things (IoMT) and AI-Enabled Chip.
We have the resources and talents to create new AI-Driven ideas in Drug Discovery, Digital Health and IoMT.
We invest in the research of New Ideas and Commercialization of Drug Discovery, Digital Health and IoMT that are innovated in our Ventures Studio or from our University Lab partners.
We recruit Grad Students, Post Grads and Professors from universities worldwide, and provide capital, mentorship and support to incubate their ideas in Drug Discovery, Digital Health and IoMT.
Our Venture Partners, shares their knowledge, skills and/or experience, develop and introduce strategic partners to the co-founders of the portfolio companies.
Our Culture
We invest at the Pre-Seed level and employ active post-investment management techniques to our portfolio that are created by talented individuals that are part of the venture studios YVLabs and YVBioMedical.
Focus
DRUG DISCOVERY
We invest in founders who are leading the industry in AI-based drug discovery and developing biotechnology platform companies. The AI-Powered Drug Discovery Platform companies, streamline R&D efforts, including calculating vast patient datasets into digestible, tangible information, identifying personalized / precision medicine opportunities or forecasting potential responses to new drugs.
DIGITAL HEALTH
The implementation of federal data-sharing regulations designed to facilitate information exchanges between healthcare organizations has prompted us to focused on:
- Artificial Intelligence-based data analytics
- Remote Patient Monitoring
- Patient Engagement
- Data Network Exchange
CONNECTED HEALTH (IoMT)
We invest in founders who lead in the innovation and development of AI-Enabled interconnected health system solutions which includes but not limited to smart devices, cloud network, wireless sensors and apps. These provide health measures of patients and transmit them back to providers – or in some cases are reported back to providers – to facilitate healthcare decisions from afar..
Portfolio
Team
Venture Studio
an AI-Focused Venture Studio that is staffed with researchers in Drug Discovery, Digital Health and Connected Health (IoMT) who are responsible for the design, prototype, and validation of our top concepts.
Upon launching a new company, we surround the startup with world-class expertise in every discipline required to build a market-leading company. We compress the amount of time it takes to move from an idea to a world-class business.
Our dedicated teams span practice areas, such as brand and design, product and engineering, talent and HR, sales and marketing, finance, and data science.
YVBioMedical aspires to be the leading AI Biotechnology Venture Studio that focuses on Drug Research, Development and IP/Technology Commercialization.
YVBioMedical to lead, integrate, and deliver multidisciplinary research focusing on Target-based Drug Discovery (TDD) that involves Phenotypic Drug Discovery (PDD) by facilitating and enhancing partnerships and collaborations between researchers, government and industry. Attracting and retaining researchers and highly qualified personnel by providing infrastructure and training that promotes creativity and entrepreneurship.
Contact
